These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16575920)

  • 1. Functional phenotyping of human plasma using a 361-fluorogenic substrate biosensing microarray.
    Gosalia DN; Denney WS; Salisbury CM; Ellman JA; Diamond SL
    Biotechnol Bioeng; 2006 Aug; 94(6):1099-110. PubMed ID: 16575920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of a SAW-biosensor with MALDI mass spectrometric analysis.
    Treitz G; Gronewold TM; Quandt E; Zabe-Kühn M
    Biosens Bioelectron; 2008 May; 23(10):1496-502. PubMed ID: 18316185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasensitive fluorogenic substrates for serine proteases.
    Butenas S; DiLorenzo ME; Mann KG
    Thromb Haemost; 1997 Oct; 78(4):1193-201. PubMed ID: 9364984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methods.
    Svendsen LG; Fareed J; Walenga JM; Hoppensteadt D
    Semin Thromb Hemost; 1983 Oct; 9(4):250-62. PubMed ID: 6658459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nature of the proteinase activated by the contact factor in human blood plasma].
    Veremeenko KN; Kizim AI; Lositskaia VM
    Vopr Med Khim; 1977; (3):391-6. PubMed ID: 196405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface plasmon resonance-enabled mass spectrometry arrays.
    Nedelkov D; Tubbs KA; Nelson RW
    Electrophoresis; 2006 Sep; 27(18):3671-5. PubMed ID: 16915566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays.
    Gosalia DN; Salisbury CM; Maly DJ; Ellman JA; Diamond SL
    Proteomics; 2005 Apr; 5(5):1292-8. PubMed ID: 15742319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays.
    Gosalia DN; Salisbury CM; Ellman JA; Diamond SL
    Mol Cell Proteomics; 2005 May; 4(5):626-36. PubMed ID: 15705970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide microarrays for serum antibody diagnostics.
    Andresen H; Bier FF
    Methods Mol Biol; 2009; 509():123-34. PubMed ID: 19212718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-assisted protease substrate screening.
    Schlüter H; Rykl J; Thiemann J; Kurzawski S; Gobom J; Tepel M; Zidek W; Linscheid M
    Anal Chem; 2007 Feb; 79(3):1251-5. PubMed ID: 17263361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of active coagulation factors in Autoplex-T with colorimetric active site-specific assay technology.
    Lundblad RL; Bergstrom J; De Vreker R; Bray G; Gomperts E; Baker D; Kingdon HS; Mann KG; Hartshorn J; Jenny RJ
    Thromb Haemost; 1998 Nov; 80(5):811-5. PubMed ID: 9843176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface plasmon resonance and surface plasmon field-enhanced fluorescence spectroscopy for sensitive detection of tumor markers.
    Arima Y; Teramura Y; Takiguchi H; Kawano K; Kotera H; Iwata H
    Methods Mol Biol; 2009; 503():3-20. PubMed ID: 19151933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A possible approach to the analysis of protease mixtures].
    Nedospasov AA; Nezavibat'ko VN; Potaman VN; Rodina EV
    Izv Akad Nauk SSSR Biol; 1989; (1):128-32. PubMed ID: 2654236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of various fluorogenic substrates for determining peptide hydrolase activity of the blood serum].
    Dilakian EA; Lokshina LA; Molodyk AA; Orekhovich VN; Pozdnev VF
    Vopr Med Khim; 1989; 35(1):131-6. PubMed ID: 2662594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future aspects of bioprocess monitoring.
    Becker T; Hitzmann B; Muffler K; Pörtner R; Reardon KF; Stahl F; Ulber R
    Adv Biochem Eng Biotechnol; 2007; 105():249-93. PubMed ID: 17408086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative evaluation of microarray slides as substrates for the development of protease assay biosensors.
    Darr CM; Castorena J; Korampally V; Gangopadhyay S; Polo-Parada L
    Exp Mol Pathol; 2011 Dec; 91(3):714-7. PubMed ID: 21945735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroimmunoassays using the NRL array biosensor.
    Golden JP; Sapsford KE
    Methods Mol Biol; 2009; 503():273-92. PubMed ID: 19151947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PNA-encoded protease substrate microarrays.
    Winssinger N; Damoiseaux R; Tully DC; Geierstanger BH; Burdick K; Harris JL
    Chem Biol; 2004 Oct; 11(10):1351-60. PubMed ID: 15489162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for mapping protease specificity.
    Diamond SL
    Curr Opin Chem Biol; 2007 Feb; 11(1):46-51. PubMed ID: 17157549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.